Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02566668 · ClinicalTrials.gov registry record
Immune Interactions in Severe Asthma
A clinical trial of Asthma, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 115
- Enrollment target
- 1
- Study location
NCT02566668: Completed study of Asthma, sponsored by University of Pittsburgh.
NCT02566668 is a study of Asthma that has completed, run by University of Pittsburgh. The registered enrollment target is 115 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02566668, a study of Asthma, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 115 participants
- Enrollment target
- 1
- Study location
Study Summary
This research study is being done to learn more about severe asthma by comparing people with severe asthma to those with milder forms of asthma and people without asthma, at baseline and over time. Individuals are being asked to join a research study to help understand the differences in the lungs and blood of participants with severe asthma compared to those with milder asthma and healthy individuals, as well as differences in overall health. Investigators also want to determine whether these differences predict asthma-related and biologic outcomes over 1 year of follow up.
Primary Outcome
Measure eotaxin-3 and IL-27 expression in bronchoalveolar lavage cells and epithelial cells.
Conditions Studied
Interventions
- OTHER 1 year Observational Follow-up
Study Locations (1)
Pennsylvania
- University of Pittsburgh Asthma Institute at UPMC - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 115 participants |
| Start Date | 2015-09 |
| Est. Completion | 2024-08-22 |
What the finished NCT02566668 record still lists
NCT02566668 is an observational study that tracks outcomes without assigning an intervention. The registered 115 participants enrollment target is mid-sized for trials with a published cap, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 1 intervention - of which 1 year Observational Follow-up is the first listed.
NCT02566668 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02566668 about?
NCT02566668 is a clinical study titled "Immune Interactions in Severe Asthma". This research study is being done to learn more about severe asthma by comparing people with severe asthma to those with milder forms of asthma and people without asthma, at baseline and over time. Individuals are being asked to join a research study to help understand the differences in the lungs a...
What is the current status of trial NCT02566668?
This trial is currently completed. The enrollment target is 115 participants. The study started on 2015-09. Estimated completion is 2024-08-22.
What conditions does trial NCT02566668 study?
This clinical trial studies the following conditions: Asthma.
What interventions are being tested in trial NCT02566668?
The interventions under investigation include: 1 year Observational Follow-up (OTHER).
Who is sponsoring clinical trial NCT02566668?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02566668 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02566668's enrollment target sits among peer trials
115 205th of 374 higher than 170 of 374 other Asthma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Asthma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Innate Immunity in Allergic Asthma
RECRUITING
-
Automated Inhaler Monitoring for Asthma Medication Usage
RECRUITING · NA
-
Impact of Metabolic Dysfunction and Mucus Plugging on Asthma Physiology
RECRUITING
-
Depemokimab Asthma Imaging and Bronchoscopy Sub-Study
RECRUITING · Phase 3
-
Escitalopram in Asthma Patients With Frequent Exacerbation
RECRUITING · Phase 2
-
Measuring the Effect of Dupilumab Treatment on Mucociliary Clearance (MCC) in Subjects With Moderate to Severe Asthma
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02346929 · 115 participants · NA
Hematoma Block for Distal Radius Fracture
- NCT03394365 · 115 participants · Phase 3
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
- NCT03907475 · 115 participants · Phase 2
Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial
- NCT05086692 · 115 participants · Phase 1
A Beta-only IL-2 ImmunoTherapY Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia